Related Experiment Videos
Miocamycin and theophylline blood levels
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy
|June 1, 1986
Summary
Miocamycin, a new macrolide antibiotic, does not affect theophylline blood levels in patients. This indicates that miocamycin can be safely co-administered with theophylline, avoiding potential drug interactions.
Area of Science:
- Pharmacology
- Microbiology
- Clinical Medicine
Background:
- Theophylline is a common medication for respiratory conditions.
- Miocamycin is a novel macrolide antibiotic with broad-spectrum activity.
- Potential drug interactions between antibiotics and theophylline require investigation.
Purpose of the Study:
- To evaluate the potential interference of miocamycin with theophylline blood concentrations.
- To determine if co-administration of miocamycin and theophylline affects pharmacokinetic profiles.
Main Methods:
- Two patient groups received either intravenous or slow-release theophylline.
- Miocamycin was administered to assess its impact on theophylline levels.
- Theophylline blood concentrations were monitored throughout the study.
Main Results:
- No significant changes in theophylline blood levels were observed in either patient group.
- Miocamycin did not demonstrate any pharmacokinetic interaction with theophylline.
Conclusions:
- Miocamycin can be safely used in conjunction with theophyllinic compounds.
- Co-administration of miocamycin and theophylline does not alter theophylline blood concentrations.
- This finding supports the use of miocamycin in patients requiring theophylline therapy.